2aHawaii
General Topics => Political Discussion => Topic started by: macsak on March 14, 2022, 07:59:42 AM
-
https://www.medrxiv.org/content/10.1101/2022.03.13.22272308v1
BNT162b2 effectiveness against symptomatic BA.1 infection was highest at 46.6% (95% CI: 33.4-57.2%) in the first three months after the second dose, but then declined to ~10% or below thereafter. Effectiveness rapidly rebounded to 59.9% (95% CI: 51.2-67.0%) in the first month after the booster dose, but then started to decline again. BNT162b2 effectiveness against symptomatic BA.2 infection was highest at 51.7% (95% CI: 43.2-58.9%) in the first three months after the second dose, but then declined to ~10% or below thereafter.
-
#needtodosomething